Want to join the conversation?
$AMGN said BLINCYTO continues to increase patient penetration in the US and launches are underway across Europe as reimbursement is secured. IMLYGIC is currently indicated as monotherapy in the US and Europe and is playing an important role in addressing the need for the small patient population.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?